Get started
Author

Ana I. Loureiro

Observed names: A I Loureiro, A. I. Loureiro, A. Loureiro, A.I. Loureiro, Ana I Loureiro, Ana Isabel Loureiro, Ana Loureiro, Ana-Isabel Loureiro
Institution: Bial (Portugal)
ORCID: 0000-0002-4676-8475
Observed ORCID: 0000-0002-4676-8475
OpenAlex ID: A5100644387
Pharmacokinetic and safety profile oftrans‐resveratrol in a rising multiple‐dose study in healthy volunteers
2009 · Luis Almeida, Manuel Vaz‐da‐Silva, et al. · Molecular Nutrition & Food Research · 443
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide
2014 · Simon Hebeisen, Nuno Pires, et al. · Neuropharmacology · 134
Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
2009 · Teresa Nunes, Luis Almeida, et al. · The Journal of Clinical Pharmacology · 115
Effect of food on the pharmacokinetic profile of trans-resveratrol
2008 · M. Vaz-da-Silva, A.I. Loureiro, et al. · International Journal of Clinical Pharmacology and Therapeutics · 105
Opicapone: a short lived and very long acting novel catechol‐ O ‐methyltransferase inhibitor following multiple dose administration in healthy subjects
2013 · José Francisco Rocha, Luis Almeida, et al. · British Journal of Clinical Pharmacology · 89
PDF
Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects: Prediction of Slow Enzyme–Inhibitor Complex Dissociation of a Short-Living and Very Long-Acting Inhibitor
2012 · Luis Almeida, José Francisco Rocha, et al. · Clinical Pharmacokinetics · 88
Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action
2015 · Patrício Soares‐da‐Silva, Nuno Pires, et al. · Pharmacology Research & Perspectives · 82
PDF
Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol
2021 · Teófilo Vasconcelos, Fabíola Prezotti, et al. · International Journal of Pharmaceutics · 73
Pharmacological profile of opicapone, a third‐generation nitrocatechol catechol‐ O ‐methyl transferase inhibitor, in the rat
2014 · M J Bonifácio, L Torrão, et al. · British Journal of Pharmacology · 55
Computation of the binding affinities of catechol‐O‐methyltransferase inhibitors: Multisubstate relative free energy calculations
2012 · P. Nuno Palma, Maria João Bonifácio, et al. · Journal of Computational Chemistry · 54
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation
2006 · P.N. Palma, M.L. Rodrigues, et al. · Molecular Pharmacology · 53
Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
2003 · P.N. Palma, M.J. Bonifácio, et al. · Drug Metabolism and Disposition · 44
Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile
2019 · Teófilo Vasconcelos, Francisca Araújo, et al. · European Journal of Pharmaceutical Sciences · 42
Enantioselective HPLC‐UV method for determination of eslicarbazepine acetate (BIA 2‐093) and its metabolites in human plasma
2007 · Gilberto Alves, Isabel Figueiredo, et al. · Biomedical Chromatography · 35
PDF
Bioavailability and Bioequivalence of??Two Enteric-Coated Formulations of??Omeprazole in Fasting and Fed Conditions
2005 · Manuel Vaz-da-Silva, Ana I Loureiro, et al. · Clinical Drug Investigation · 31
Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat
2014 · Bruno Igreja, Nuno Miguel Pires, et al. · Hypertension Research · 29
PDF
Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma
2011 · A.I. Loureiro, C. Fernandes-Lopes, et al. · Journal of Chromatography B · 28
Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection
2007 · Gilberto Alves, Isabel Figueiredo, et al. · Analytica Chimica Acta · 27
PDF
A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing
2020 · Inês B. Correia-Sá, Cláudia M. Carvalho, et al. · Scientific Reports · 26
PDF
Human Metabolism of Nebicapone (BIA 3-202), a Novel Catechol-O-Methyltransferase Inhibitor: Characterization of in Vitro Glucuronidation
2006 · A.I. Loureiro, M.J. Bonifácio, et al. · Drug Metabolism and Disposition · 26
Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase
2018 · László E. Kiss, Alexandre Beliaev, et al. · ChemMedChem · 25
PDF
Single‐Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5–453), a New Dopamine β‐Hydroxylase Inhibitor, in Healthy Subjects
2011 · José Francisco Rocha, Manuel Vaz‐Da‐Silva, et al. · The Journal of Clinical Pharmacology · 25
Pharmacokinetic?pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
2003 · Pedro Silveira, Manuel Vaz-da-Silva, et al. · European Journal of Clinical Pharmacology · 23
PDF
Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy
2013 · Heidrun Potschka, Jonna Soerensen, et al. · Epilepsy Research · 22
N-Acetylation of Etamicastat, a Reversible Dopamine-β-Hydroxylase Inhibitor
2013 · Ana I. Loureiro, Carlos Fernandes-Lopes, et al. · Drug Metabolism and Disposition · 21
Works count: 72
Citation count: 1,943
H-index: 23
I10-index: 35
Year
Topic
Type